Moreover, we found that the autocrine scFv PD-L1 antibody enhanced the antitumor efficacy of Her2.BBz CAR T cells against HCC1954 breast cancer xenograft tumors, showing a significant decrease in tumor growth and tumor weight (Figure 6). This evidence concerns the gene ERBB2 and neoplasm.